RJA
SYRS

Raymond James & Associates’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History

Raymond James & Associates’s Portfolio SYRS Stock Details SYRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-1,550
Closed -$84K – 4063
2021
Q2 		$84K Buy
+1,550
New +$84K ﹤0.01% 3807